nach oben

Erschienen in:

07.08.2017

The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain

verfasst von: Constanza Daigre, Lara Grau-López, Laia Rodríguez-Cintas, Elena Ros-Cucurull, Marta Sorribes-Puertas, Oriol Esculies, Katia Bones-Rocha, Carlos Roncero

Erschienen in: Quality of Life Research | Ausgabe 12/2017

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

The comorbidity of any substance use disorder and another mental disorder is defined as dual diagnosis. Dual diagnosis is very common and clinical and therapeutic consequences have been described. This cross-sectional study aimed to analyse health-related quality of life (HRQoL) according to clinical characteristics and psychiatric comorbidities in patients with substance dependence.

Methods

A total of 1276 substance-dependent patients seeking treatment were recruited. HRQoL was evaluated by the Short-Form 36 (SF-36) questionnaire. The SCID-I, SCID-II and Conners’ adult ADHD diagnostic interview were used to evaluate dual diagnosis. A visual analogue scale was used to measure craving. Bivariate and multivariate analyses were performed, and correction for multiple tests was conducted.

Results

Substance-dependent patients had impaired quality of life, especially in the mental component. SF-36 physical and mental component scores were 47.7 ± 10.9 and 36.1 ± 14.1, respectively. Furthermore, 65% of the patients had dual diagnosis, 51% had an Axis I DSM-IV-TR mental disorder and 35% had some personality disorder. Impaired physical quality of life was independently associated with medical condition, age, being female, depressive disorder and anxiety disorder. Depression disorder, any personality disorder, active consumption last month, Attention deficit hyperactivity disorder, anxiety disorder, suicide attempt were independently associated with worse mental quality of life.

Conclusion

These findings emphasize the significance of dual diagnosis in the impairment of HRQoL in substance-dependent patients, particularly with regard to mental component. In addicted patients with low scores on SF-36, psychiatric comorbidity should be evaluated and treated in an integrated approach.

Vorheriger Artikel Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments

Nächster Artikel Standardization of health outcomes assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Gowing, L. R., Ali, R. L., Allsop, S., Marsden, J., Turf, E. E., West, R., et al. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction (Abingdon, England), 110(6), 904–919. doi:10.1111/add.12899.CrossRef

EMCDDA (2016). European Drug Report 2016: Trends and developments. http://www.pnsd.msc.es. Lisbon.

Luquiens, A., Reynaud, M., Falissard, B., & Aubin, H. J. (2012). Quality of life among alcohol-dependent patients: how satisfactory are the available instruments? A systematic review. Drug and Alcohol Dependence, 125(3), 192–202. doi:10.1016/j.drugalcdep.2012.08.012.CrossRefPubMed

Roncero, C., Díaz-Morán, S., Comín, M., Miquel, L., Gonzalvo, B., & Casas, M. (2011). Quality of life concept evolution: The subjective dimension as a relevant factor on drug addiction. Vertex, 22(99), 343–349.PubMed

Hasin, D., & Kilcoyne, B. (2012). Comorbidity of psychiatric and substance use disorders in the United States: Current issues and findings from the NESARC. Current Opinion in Psychiatry, 25(3), 165–171. doi:10.1097/YCO.0b013e3283523dcc.CrossRefPubMedPubMedCentral

Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martinez-Luna, N., Casas, M., et al. (2016). Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiatry Research, 243, 174–181. doi:10.1016/j.psychres.2016.06.024.CrossRefPubMed

Daigre, C., Roncero, C., Grau-López, L., Martínez-Luna, N., Prat, G., Valero, S., et al. (2013). Attention deficit hyperactivity disorder in cocaine-dependent adults: A psychiatric comorbidity analysis. The American Journal on Addictions, 22(5), 466–473. doi:10.1111/j.1521-0391.2013.12047.x.CrossRefPubMed

Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., et al. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry, 183, 304–313.CrossRefPubMed

Calsyn, D. A., Saxon, A. J., Bush, K. R., Howell, D. N., Baer, J. S., Sloan, K. L., et al. (2004). The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: Concurrent and discriminant validity. Drug and Alcohol Dependence, 76(2), 165–171. doi:10.1016/j.drugalcdep.2004.04.018.CrossRefPubMed

10.

de Moreira, T. C., Figueiró, L. R., Fernandes, S., Justo, F. M., Dias, I. R., Barros, H. M. T., et al. (2013). Quality of life of users of psychoactive substances, relatives, and non-users assessed using the WHOQOL-BREF. Ciência & Saúde Coletiva, 18(7), 1953–1962.CrossRef

11.

Lugoboni, F., Mirijello, A., Faccini, M., Casari, R., Cossari, A., Musi, G., et al. (2014). Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug and Alcohol Dependence, 142, 105–109. doi:10.1016/j.drugalcdep.2014.06.020.CrossRefPubMed

12.

Mcpherson, A., & Martin, C. R. (2013). A review of the measurement properties of the 36-item short-form health survey (SF-36) to determine its suitability for use in an alcohol-dependent population: Use of SF-36 in alcohol-dependency. Journal of Psychiatric and Mental Health Nursing, 20(2), 114–123. doi:10.1111/j.1365-2850.2012.01896.x.CrossRefPubMed

13.

Román, E., Córdoba, J., Torrens, M., Guarner, C., & Soriano, G. (2013). Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis. European Journal of Gastroenterology and Hepatology, 25(1), 77–84.CrossRefPubMed

14.

Chahua, M., Sánchez-Niubò, A., Torrens, M., Sordo, L., Bravo, M. J., Domingo-Salvany, A., et al. (2015). Quality of life in a community sample of young cocaine and/or heroin users: The role of mental disorders. Quality of Life Research, 24(9), 2129–2137. doi:10.1007/s11136-015-0943-5.CrossRefPubMed

15.

Astals, M., Domingo-Salvany, A., Buenaventura, C. C., Tato, J., Vazquez, J. M., Martín-Santos, R., et al. (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use and Misuse, 43(5), 612–632. doi:10.1080/10826080701204813.CrossRefPubMed

16.

Yen, C. N., Wang, C. S. M., Wang, T. Y., Chen, H. F., & Chang, H. C. (2011). Quality of life and its correlates among heroin users in Taiwan. The Kaohsiung Journal of Medical Sciences, 27(5), 177–183. doi:10.1016/j.kjms.2010.09.003.CrossRefPubMed

17.

Miranda, J. F., García-Portilla, M. G., Martínez, P. S., Cienfuegos, E. G., & García, J. B. (1999). Calidad de vida y severidad de la adicción en heroinómanos en mantenimiento prolongado con metadona. Adicciones, 11(1), 43–52.CrossRef

18.

Costenbader, E. C., Zule, W. A., & Coomes, C. M. (2007). The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection. Drug and Alcohol Dependence, 89(2–3), 251–258. doi:10.1016/j.drugalcdep.2007.01.006.CrossRefPubMedPubMedCentral

19.

Díaz-Morán, S., Palma-Álvarez, R. F., Grau-López, L., Daigre, C., Barral, C., Ros-Cucurull, E., et al. (2015). Self-perceived quality of life in cocaine dependents with or without dual diagnosis. Salud Mental, 38(6), 397–402. doi:10.17711/SM.0185-3325.2015.053.CrossRef

20.

Bagheri, M., Mokri, A., Khosravi, A., & Kabir, K. (2015). Effect of abstinence on depression, anxiety, and quality of life in chronic methamphetamine users in a therapeutic community. International Journal of High Risk Behaviors and Addiction. doi:10.5812/ijhrba.23903.PubMedPubMedCentral

21.

Iraurgi Castillo, I., Póo, M., & Márkez Alonso, I. (2004). Valoración del índice de salud sf-36 aplicado a usuarios de programas de metadona: valores de referencia para la Comunidad Autónoma Vasca. Revista española de salud pública, 78(5), 609–621.CrossRefPubMed

22.

Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRefPubMed

23.

Ware, J. E., & Kosinski, M. (2001). Interpreting SF-36 summary health measures: a response. Quality of Life Research, 10(5), 405–413.CrossRefPubMed

24.

Apolone, G., Brazier, J., Bullinger, M., Kama, S., Leplège, A., Prieto, L., et al. (1998). The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the 1QOLA project. Journal of Clinical Epidemiology, 51(11), 1167–1170.CrossRefPubMed

25.

Lee, J. W., Brown, E. S., Perantie, D. C., & Bobadilla, L. (2002). A comparison of single-item visual analog scales with a multiitem likert-type scale for assessment of cocaine craving in persons with bipolar disorder. Addictive Disorders & Their Treatment, 1(4), 140–142.CrossRef

26.

First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012). Structured clinical interview for DSM-IV ^® Axis I disorders (SCID-I), Clinician Version, Administration Booklet. New York: American Psychiatric Pub.

27.

First, M. B. (1997). User’s guide for the structured clinical interview for DSM-IV Axis II personality disorders: SCID-II. New York: American Psychiatric Pub.

28.

Epstein, J. N., & Kollins, S. H. (2006). Psychometric properties of an adult ADHD diagnostic interview. Journal of Attention Disorders, 9(3), 504–514. doi:10.1177/1087054705283575.CrossRefPubMed

29.

Heslin, K. C., Stein, J. A., Heinzerling, K. G., Pan, D., Magladry, C., & Hays, R. D. (2011). Clinical correlates of health-related quality of life among opioid-dependent patients. Quality of Life Research, 20(8), 1205–1213. doi:10.1007/s11136-011-9858-y.CrossRefPubMedPubMedCentral

30.

Vilagut, G., Ferrer, M., Rajmil, L., Rebollo, P., Permanyer-Miralda, G., Quintana, J. M., et al. (2005). El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gaceta Sanitaria, 19(2), 135–150.CrossRefPubMed

31.

Alonso, J., Regidor, E., Barrio, G., Prieto, L., Rodríguez, C., & de la Fuente, L. (1998). Population reference values of the Spanish version of the Health Questionnaire SF-36. Medicina Clínica, 111(11), 410–416.PubMed

32.

Moore, A. A., Seeman, T., Morgenstern, H., Beck, J. C., & Reuben, D. B. (2002). Are there differences between older persons who screen positive on the CAGE questionnaire and the Short Michigan Alcoholism Screening Test—Geriatric Version? Journal of the American Geriatrics Society, 50(5), 858–862.CrossRefPubMed

33.

Malmusi, D., Artazcoz, L., Benach, J., & Borrell, C. (2012). Perception or real illness? How chronic conditions contribute to gender inequalities in self-rated health. The European Journal of Public Health, 22(6), 781–786. doi:10.1093/eurpub/ckr184.CrossRefPubMed

34.

Strine, T. W., Mokdad, A. H., Dube, S. R., Balluz, L. S., Gonzalez, O., Berry, J. T., et al. (2008). The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. General Hospital Psychiatry, 30(2), 127–137. doi:10.1016/j.genhosppsych.2007.12.008.CrossRefPubMed

35.

Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., et al. (2015). Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: A scientific statement from the American heart association. Circulation, 132(10), 965–986. doi:10.1161/CIR.0000000000000229.CrossRefPubMed

36.

Celano, C. M., Daunis, D. J., Lokko, H. N., Campbell, K. A., & Huffman, J. C. (2016). Anxiety disorders and cardiovascular disease. Current Psychiatry Reports, 18(11), 101. doi:10.1007/s11920-016-0739-5.CrossRefPubMedPubMedCentral

37.

Dinkel, A., Kremsreiter, K., Marten-Mittag, B., & Lahmann, C. (2014). Comorbidity of fear of progression and anxiety disorders in cancer patients. General Hospital Psychiatry, 36(6), 613–619. doi:10.1016/j.genhosppsych.2014.08.006.CrossRefPubMed

38.

Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8–19.CrossRefPubMed

39.

Herrero, M. J., Domingo-Salvany, A., Torrens, M., Brugal, M. T., & ITINERE Investigators. (2008). Psychiatric comorbidity in young cocaine users: induced versus independent disorders. Addiction (Abingdon, England), 103(2), 284–293. doi:10.1111/j.1360-0443.2007.02076.x.CrossRef

40.

Srisurapanont, M., Likhitsathian, S., Chua, H. C., Udomratn, P., Chang, S., Maneeton, N., et al. (2015). Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder. Journal of Affective Disorders, 186, 26–31. doi:10.1016/j.jad.2015.06.032.CrossRefPubMed

41.

Martínez, J. M., Graña, J. L., & Trujillo, H. (2011). Longitudinal study on quality of life, craving and psychological adjustment in alcohol-dependent patients: variations depending on the personality disorders. Adicciones, 23(3), 227–235.CrossRef

42.

Walter, K. N., & Petry, N. M. (2016). Lifetime suicide attempt history, quality of life, and objective functioning among HIV/AIDS patients with alcohol and illicit substance use disorders. International Journal of STD and AIDS, 27(6), 476–485. doi:10.1177/0956462415585668.CrossRefPubMed

43.

Wilcox, H. C., Conner, K. R., & Caine, E. D. (2004). Association of alcohol and drug use disorders and completed suicide: An empirical review of cohort studies. Drug and Alcohol Dependence, 76(Suppl), S11–S19. doi:10.1016/j.drugalcdep.2004.08.003.CrossRefPubMed

44.

Hasin, D. S., & Grant, B. F. (2015). The national epidemiologic survey on alcohol and related conditions (NESARC) waves 1 and 2: Review and summary of findings. Social Psychiatry and Psychiatric Epidemiology, 50(11), 1609–1640. doi:10.1007/s00127-015-1088-0.CrossRefPubMedPubMedCentral

45.

Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576. doi:10.1001/archpsyc.64.5.566.CrossRefPubMed

46.

McGovern, M. P., Lambert-Harris, C., Gotham, H. J., Claus, R. E., & Xie, H. (2014). Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems. Administration and Policy In Mental Health, 41(2), 205–214. doi:10.1007/s10488-012-0449-1.CrossRefPubMedPubMedCentral

47.

Szerman, N., Vega, P., Grau-López, L., Barral, C., Basurte-Villamor, I., Mesías, B., et al. (2014). Dual diagnosis resource needs in Spain: A national survey of professionals. Journal of Dual Diagnosis, 10(2), 84–90. doi:10.1080/15504263.2014.906195.CrossRefPubMed

Titel: The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain
verfasst von: Constanza Daigre
Lara Grau-López
Laia Rodríguez-Cintas
Elena Ros-Cucurull
Marta Sorribes-Puertas
Oriol Esculies
Katia Bones-Rocha
Carlos Roncero
Publikationsdatum: 07.08.2017
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 12/2017
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1668-4

Springer Professional

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 12/2017

Sample size determination for EQ-5D-5L value set studies

Selection of key health domains from PROMIS® for a generic preference-based scoring system

Quality of life among German parents of children with cystic fibrosis: the effects of being a single caregiver

Social inequalities in children’s oral health-related quality of life: the Generation R Study

Do male esophageal cancer patients have impaired sexual function after esophagectomy? A self-reported outcomes study

Associations between health-related quality of life, cardiorespiratory fitness, muscle strength, physical activity and waist circumference in 10-year-old children: the ASK study

Premium Partner